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Thiol-containing bioreducible polymers show significant potential as delivery 
vectors in gene therapy, a rapidly growing field which seeks to treat genetic-based 
disorders by delivering functional synthetic genes to diseased cells. Studies have 
shown that thiolated polymers exhibit improved biodegradability and prolonged in 
vivo circulation times over non-thiolated polymers. However, the extent to which 
thiol concentrations impact the carrier’s delivery potential has not been well explored. 
The aim of this dissertation is to investigate how relative concentrations of free thiols 
and disulfide crosslinks impact a polymeric carriers delivery performance with 
respect to DNA packaging, complex stability, cargo protection, gene release, 
internalization efficiency and cytotoxicity. To accomplish this goal, several 
fluorescent polymers containing varying concentrations of thiol groups were 
synthesized by conjugating thiol-pendant chains onto the primary amines of cationic 
poly(allylamine). In vitro delivery assays and characterization techniques were 
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Chapter 1  
1.1    Overview 
With the recognition of inter-individual differences in drug response, the health 
industry is slowly moving towards the development of personalized medicine for optimal 
treatment with minimal side effects. The emerging field of gene therapy fulfills these 
needs and is considered the next generation in therapeutics.
1
 The goal of gene therapy is 
to treat genetic-based disorders such as Alzheimer’s, cystic fibrosis, and muscular 
dystrophy, by replacing the disease-causing gene with a functional synthetic gene. Gene 
therapy also aims to treat neurological, cardiovascular, and infectious diseases by 
developing synthetic genes that encode for cytotoxic proteins or prodrug activity.
2
 
Tumors, for example, can be targeted with tumoricidal or tumor suppressing genes.
3
 Thus 
far, the therapeutic efficiency of synthetic genes has been proven in both animal and 
clinical studies.
4-10
 However, the full potential of gene therapy has yet to be fulfilled due 
to challenges associated with delivery methods such as cell targeting specificity, 
transfection efficiency, gene expression regulation, and safety.
11
 Statistics show that 
despite the therapeutic efficiency of synthetic genes, over 95% of clinical trials never 
reach phase III studies due to safety concerns involving gene delivery methods.
12
 
Direct delivery of “naked DNA” into targeted tissues is by far the simplest delivery 
method used in gene delivery. Several challenges, associated with the size and charge of 
naked DNA, prevent this strategy from being applied with reasonable efficacy.
12-14
 
Studies have shown that the DNA’s negative charge hinders cellular internalization. 
Further, due to its small size, naked DNA is readily degraded within the bloodstream 
upon systemic administration. Delivery vectors are therefore necessary for the successful 
2 
 
delivery of therapeutic genes to cells.
13, 15
 Successful gene carriers must have the 
capability to overcome a number of intracellular and extracellular obstacles including 




Engineered viral capsids were the first vectors employed for gene delivery. Initial 
reports of clinical implementation showed that viral vectors had severe and even deadly 
side effects. In 2000, an 18 year old girl who participated in an ornithine transcarboxylase 
deficiency clinical trial at the University of Pennsylvania (UPenn) died as a result of an 
inflammatory reaction to an adenovirus based vector.
17
 After the death of second UPenn 
volunteer, the US Food and Drug Administration (FDA) halted seven ongoing clinical 
trials at the university.
18
 Then in 2002, a 3 year old boy treated with gene therapy at a 
hospital in France developed a leukemia-like clonal lymphocyte proliferation as a result 
of a retroviral vector.
19, 20
 This time the US FDA halted over two dozen clinical trials.
20, 21
 
The clinical challenges associated with viral vectors have motivated researchers to 
explore synthetic polymers as a safer delivery alternative.
22
 Unlike viral vectors, 
polymeric carriers can be chemically and structurally modified to overcome several of the 
discussed challenges. The polymer’s molecular weight, polydispersity, chain 
composition, and chain density can be altered to improve the carrier’s delivery efficiency. 
In addition, polymers pose lesser risk of immunogenicity than viral vectors, carry no risk 






1.2    Objectives 
Thiol containing bioreducible polymers are especially attractive as delivery vectors 
because of their intrinsic ability to respond to environmental stimuli.
25, 26
 Thiols (SH) 
readily form disulfide bonds (S-S) in an oxidation reaction which can be controlled by 
solution viscosity, pH, and temperature. The disulfides remain relatively stable in 
oxidizing environments such as the extracellular space, but are readily reduced in the 
intracellular reducing environment of cells.
25
 Previously, studies have shown that 
polymer-gene complexes (polyplexes) formed with bioreducible polymers remain intact 
in the circulatory system, but degrade within the intracellular space for high cargo 
release.
15, 27
 However, the extent to which thiol concentrations and degree of crosslinking 
impact the carriers delivery potential have not been well explored.  
The aim of this dissertation is to investigate how relative concentrations of free thiols 
and disulfide crosslinks impact a polymeric carriers delivery performance with respect to 
DNA packaging, complex stability, cargo protection, gene release, internalization 
efficiency and cytotoxicity. To accomplish this goal, several fluorescent polymers 
containing varying concentrations of thiol groups were synthesized by conjugating thiol-
pendant chains onto the primary amines of cationic poly (allylamine) PAA. Synthesis of 
thiolated polymers was verified by 
1
H NMR. The relative concentration of thiol groups 
and the extent of disulfide crosslinking were determined by 5,5'-dithiobis-(2-nitrobenzoic 
acid) (DNTB) assay. Techniques such as gel electrophoresis, UV spectrophotometry, 
fluorescent microscopy, and dynamic light scattering were employed to characterize 
DNA binding/release, polyplex size and stability, and delivery potential. Transfection 
efficiency was determined by delivering plasmid DNA to breast cancer cells. 
4 
 
1.3    Mechanism of Polymeric Gene Delivery 
Polymeric gene delivery begins with the packaging of genetic cargo by a polymer 
carrier. The resulting polyplexes are internalized by cells through non-specific adsorptive 
endocytosis or receptor-mediated endocytosis.
1, 11
 In receptor-mediated endocytosis, 
polymer complexes carry targeting ligands that bind to specific receptors located on cell 
surfaces and trigger internalization.
11, 28
 Non-specific endocytosis results from 
electrostatic interactions arising between positively charged polymeric carriers and 
negatively charged carboxylated glycosaminoglycans (GAGs) present on the cell’s 
surface. Both ligand-receptor and polymer-GAG interactions cause the cellular 
membrane to invaginate, thus engulfing polyplexes in a membranous vesicle known as 
the endosome. Initially, the endosome has a pH~7. However, as the vesicle matures into a 
lysosome, the internal pH drops to ~4. Polyplexes that do not escape prior to maturation 
are degraded by lysosomal enzymes.
28
 Many cationic polymers have the ability to escape 
the endolysosome through the proton sponge effect; a phenomenon in which polymers 
absorb protons from the incoming cytosol and swell, thereby rupturing the endolysosome 
and releasing the DNA cargo into the cell cytosol. Once released, the cargo is transported 
to the nucleus for transcription.
11
 The mechanism of polymeric gene delivery is depicted 















1.4    Challenges in Gene Delivery 
The extracellular and intracellular challenges associated with gene delivery are 
depicted in Figure 2.
29
 This section reviews the primary challenges associated with 
polymeric gene delivery and discusses current methods employed to overcome them.  
 
 








1.4.1    Extracellular Barriers 
1.4.1.1    Gene Packaging 
The primary goal of gene packaging is to produce complexes of optimal size and 
composition for cellular uptake. There are three main packaging strategies that are 
currently being employed in polymeric gene delivery; electrostatic interaction, 













         1.4.1.1.1     Electrostatic Interactions  
Electrostatic interactions between the polymer’s positively charged amines and the 
DNA’s negatively charged phosphates are the primary driving forces behind DNA 
condensation.
30
 Studies have shown that approximately 90% of the negative charges on 
the DNA phosphate backbone must be overcome for condensation to occur.
31
 However, 
at a sufficient amine to phosphate ratio (N/P ratio), polyplexes form spontaneously upon 
mixing. The resulting particles have a toroidal or rod-like shape ranging from 30 to 
several hundred nm in diameter.
2
 Polyplex size, charge, and stability can be altered by 
changing the N/P ratio.
32
 
         1.4.1.1.2     Encapsulation 
An alternative packaging strategy is via hydrogel encapsulation. Hydrogels are 
crosslinked polymers with the ability absorb water without dissolving. The majority of 
hydrogels employed in gene delivery contain ester or disulfide linkages along their 
backbone. These bonds are readily hydrolyzed within the cell, allowing for more efficient 
DNA cargo release. The degradation kinetics of hydrogels can be modulated by altering 
the gels physicochemical properties, such as crosslink density. Hence, hydrogels can be 
customized to respond to environmental stimuli such as pH or temperature.
11
 
Hydrogel-DNA particles in gene delivery are primarily formed by reverse emulsion, a 
technique in which monomer units and DNA strands are added to a hydrophobic solution 
containing amphiphilic emulsifier. Emulsifiers form micelles with non-ionic surfaces and 
charged cores. Since monomer units and DNA strands prefer the charged environment, 
they migrate into the micelle core. At this point, monomers and crosslinkers polymerize 
9 
 
to form a hydrogel structure loaded with DNA cargo. The major limitation of this method 




         1.4.1.1.3    Adsorption 
Adsorption involves conjugating cationic moieties onto the surface of biodegradable 
polymers so that DNA can electrostatically bind. The advantage of this technique is that 
it leaves the DNA readily available for release within the cell.  However, because the 




1.4.1.2    Serum Stability 
The body’s defense system is built so that it quickly identifies and eliminates foreign 
moieties. When systematically administered, cationic polymers interact with negatively 
charged serum proteins. As a result, polyplexes are rapidly cleared by the phagocytic 
cells of the mononuclear phagocyte system (MPS) in the liver, spleen, lungs and bone 
marrow.
2, 23
 To minimize polymer-protein interactions, hydrophilic polymers, such as 
poly (ethylene) glycol (PEG) and N-(2-hydroxypropyl)methacrylamide (HPMA),
 
can be 
grafted onto the polymer chain as a “brush” as shown in Figure 4.
2, 23
 The molecular 
brush acts to sterically block polymer-protein interactions, thereby reducing particle 
aggregation and increasing the solubility of the polymer-DNA complexes. Studies have 
shown that the application of hydrophilic monomers can increase systemic circulation 
times of intravenously administered complexes.
1, 33








1.4.1.3    Cell Specific Targeting and Internalization 
The relative importance of targeted cell specificity depends on the disease being 
treated. For some diseases, such as hemophilia, the identity of the transduced cells is not 
important so long as sufficient quantities of the delivered therapeutic gene are expressed. 




To improve transfection cell specificity, targeting ligands are conjugated onto 
polyplex surfaces to facilitate receptor-mediated endocytosis.
11
 Transferrin (Tf), for 
example, is a highly hydrophilic negatively charged protein that binds and delivers iron to 
cells through the transferrin receptor (Tf-R) located on cell surfaces. Dividing cancer 
cells exhibit elevated levels of transferrin receptors due to their need for iron, making Tf 
a potential targeting moiety for gene delivery to tumors.
34
 Studies have demonstrated that 
in addition to actively targeting tumor cells, Tf also shields the surface charge of 
polyplexes, thereby decreasing interaction with plasma components, erythrocytes and 
non-target cells.
35
 The success of ligand targeting depends on polymer-ligand conjugation 
11 
 
chemistry, distance between ligand and polymer complexes, ligand-receptor binding 
strength, and ligand density.
11
 
In non-specific delivery, polyplexes are internalized by non-adsorptive endocytosis 
involving polymer-GAG interactions, as previously described.
1,11
 Studies have shown 
that differences in proteoglycan distributions between cells types can lead to varying 
degrees of polymer-DNA uptake between cells.
11
 Currently, cell-penetrating peptides 
(CPP) are being investigated for their ability to facilitate polymer internalization. It is 
hypothesized that these peptides work by one of three strategies; direct penetration of 
cellular membrane, induced endocytosis, and/or membrane pore formation. Originally 













1.4.2    Intracellular Barriers 
1.4.2.1    Endolysosomal Escape 
Due to size restrictions, polymer complexes typically cannot diffuse into cells, and 
must therefore be internalized by endocytosis, a multistep process in which cells engulf 
molecules from the extracellular matrix. As polymers interact with the cell surface, a 
portion of the cell’s membrane is invaginated and pinched off, forming a membrane 
bound vesicle called an endosome. Upon internalization, the endosome compartment has 
a pH~7, which ultimately drops to pH~4 as the vesicle matures from an endosome to a 
lysosome.
28
 Polyplexes that do not escape the endolysosome are eventually degraded by 
enzymes present in the lysosome.
11
  
The most commonly used method for endosomal escape is via pH-sensitive 






 amines, imidazole) exhibiting pKa values 
between 5 and 7. Once in the acidic environment of the cell, amines located on the 
polymer backbone protonate by absorbing protons from the incoming cytosol. This 
phenomenon, also known as the proton sponge effect, induces osmotic swelling. As a 
result, the endolysosome ruptures and the genetic cargo is released into the cytosol.
1, 11
 A 
polymer potential to escape the endosome is measured by its buffering capacity. Cationic 
polymers including poly(ethyleneimine), poly (2-dimethylamino) ethyl methacrylate 
(PDMAEMA), and polyamidoamines have high buffering capacities and can therefore 
escape the endolysosome through the proton sponge mechanism. Other cationic 
polymers, such as poly-L-lysine and poly(allylamine) have a low number of protonizable 
13 
 
amines and therefore a low buffering capacity. These polymers can only escape the 
endosome with the aid of a lysosomotropic agent, such as chloroquin.
36
  
1.4.2.2    Cytotoxicity 
Polymer biocompatibility and cell viability in vitro must be sufficiently demonstrated 
before polymer delivery systems can be introduced into clinic trials.
37
 Studies have 
shown that polymer cationic charge is correlated to cell toxicity. The theory is that 
electrostatic interactions between the positively charged polymer and the negatively 
charged cell membrane cause the polymers to aggregate at the cell surface, thereby 
disturbing membrane structure and function.
38, 39
 When systematically administered 
cationic polymers show high accumulation in the lungs, liver, and spleen. Not only does 




Structural and non-structural parameters that promote polymer-cell and polymer-
protein interaction, such as polymer molecular weight, degree of branching, charge 
density, polyplex size and stability, and ionic strength of solution, can intensify cytotoxic 
effects.
11, 40
 Reports have demonstrated that high molecular weight (HMW) polymers 
exhibit higher cytotoxicities than low molecular weight polymers (LMW).
41-46
 
Researchers have tried to overcome this problem linking non-toxic LMW polymers via 
degradable linkages to form HMW polymers.
11,24
  
Another common method of lowering cytotoxicty is by decreasing the polymer’s 
cationic charge. This can be accomplished by grafting non-ionic molecules onto the 
cationic polymer. For example, when PEG is functionalized onto the backbone of a 
14 
 
cationic polymer, polyplex aggregation at the cell surface and cytotoxicity are decreased. 
At the same time, in vivo circulation time is increased due to minimized polyplex-protein 
interactions.
11
 In vitro studies using COS-1 and HEK293 cell lines indicate that cell 
cultures transfected with PEGylated PAA have 10% more viability than PAA transfected 
cells. In addition, heterocyclic rings, such as imidazolyl and pyridinium, have been 
shown to lower toxicity by spreading the cationic charge of the headgroup.
47, 48
 
Finally, there is also evidence that polymer interactions with cell proteins can affect 
protein function and cell function.
39
  Polymer amines have been shown to disrupt the 
function of protein kinase C, a family of enzymes involved in a range of regulatory 
activities including receptor desensitization, cell growth, and transcription, through the 











1.5    Cationic Polymers 
Amine-rich cationic polymers have been given a lot of attention in gene delivery due 
to their ability to condense DNA into nanosized complexes. Studies have shown that at a 
sufficient N/P ratio, polyplexes form spontaneously upon mixing. The size of the 
resulting particles ranges from 30 to several hundred nm, depending on N/P ratio.
2, 32
 In 
addition, cationic polymers have the ability to escape endolysosomal degradation via the 
proton sponge effect. Although more than 95% of cells in a culture internalize polyplexes 
during a given transfection, less than 50% of cells express the gene. From this standpoint, 
a polymers success is dependent upon its ability to buffer at endolysosomal pH.
2
  
The following section briefly reviews several of the most commonly employed 










1.5.1    Common Cationic Polymers 
1.5.1.1    Poly(ethylene imine) 
 
Figure 5. PEI precursors and products 
49
 
Polyethyleneimine (PEI) is perhaps the most commonly used cationic polymer due to 
its extraordinary buffering capacity.
48, 49
 PEI comes in two forms: linear (l-PEI) and 
branched (b-PEI), as shown in Figure 5.
49
  Branched PEI is synthesized by an acid 
catalyzed ring opening polymerization of aziridine monomers. The resulting polymer has 
a high number of unprotonated amine groups, which are responsible for b-PEIs high 
buffering capacity. Linear PEI is formed via cationic polymerization of 2-oxazoline 
monomer. Unlike b-PEI, 90% of l-PEI amines are already protonated at physiological 
pH.
49
 As a result, l-PEI has a high cationic density which allows it to bind and condense 
DNA into small particles. However, the already protonated amines hinder l-PEI’s 
17 
 
buffering capacity. Since transfection success if highly dependent on buffering capacity, 
b-PEI has significantly greater delivery rates than l-PEI.
1
  
The transfection success of PEI has been well documented. Boussif et al.,
50
 for 
example, demonstrated transfection of PEI polymers in over 25 cell lines, including 18 
human cell lines. Reports have shown that PEI’s molecular weight, which can be 
controlled through initiator concentrations and temperature during the polymerization 
process, is directly proportional to the carrier’s cytotoxicity and transfection efficiency.
11, 
49
 In a series of experiments, Xiong et al.,
51
 compared low molecular weight PEI with 
800 Da (PEI 800) with high molecular weight PEI (PEI25k) Results showed that 
PEI25k–DNA complexes were more compact, with particle diameters averaging less than 
100 nm at N/P ratios between 10 and 40. Under similar conditions, PEI800 could not 
form condense DNA, most likely because the polymer was unable to wrap around the 
plasmid DNA. As a result, PEI800 exhibited much lower transfection efficiencies. 
However, PEI25 also exhibited much greater cytotoxicity than PEI800.
42
 
Transfection efficiency and biodegradability of b-PEI can be improved by linking 
together short PEI segments via biodegradable linkages. Studies have shown that peptide 
based analogues of PEI800 can reach transfection efficiencies similar to those of PEI25k, 








1.5.1.2    Poly-L-lysine 
 
 Figure 6: Chemical structure of PLL and some of its derivatives 
52
 
Cationic poly-L-lysine (PLL) is one of the first polymers investigated for its 
application in gene therapy.
1
 PLL synthesis begins with the conversion of an e-amino 
lysine monomer into lysine anhydride. Ring opening polymerization is performed using 
an initiator containing l-lysine anhydride. The molecular weight is controlled by changing 
the feed ratio of monomer to initiator.  
In general, HMW PLL is capable of condensing and protecting DNA. However, 
much like PEI, low molecular weight PLLs do not form stable complexes with DNA. 
Further, HMW PLLs elicit significant toxicity, making them unsuitable delivery carriers. 
In addition, since all of the e-amino groups of PLL are protonated at physiological pH, 





In attempt to improve the safety profiles of PLL vectors, targeting moieties including 
sugars, antibodies, and peptides, have been conjugated onto the polymer’s backbone as a 
means of increasing cell specificity and reducing polyplex aggregation. PEGylation has 
also been shown to ameliorate PLL’s toxic effects.
52
 In addition, amino acids with low 
pka values can be grafted onto the PLL chain to improve transfection rates.
53
 
Finally, studies have also investigated how the structural differences between 
dendritic PLL (D-PLL) and linear PLL (l-PLL) affect the functionality and efficiency of 
the polymers in gene delivery. Yamagate et al., 
54
 demonstrated that cells transfected with 
l-PLL internalized nearly 3x more DNA than cells transfected with d-PLL, but still had 
exhibited lower gene expression than d-PLL transfected cells. From these data it can be 
inferred that the low delivery success of PLL polymers does not result from inefficient 













1.4.1.3    Poly (2-dimethylamino) ethyl methacrylate 
 




Methacrylate polymers have excellent biocompatibility and have already been 
employed for medical purposes, such as the fabrication of contact lenses. Gene delivery 
studies have focused on one type of methacrylate polymer, (2dimethylamino) ethyl 
methacrylate (pDMAEMA), due to its superior transfection efficiency.
55
 
pDMAEMA is synthesized by radical polymerization with an ammonium peroxide 
sulfate initiator as shown in Figure 7.1 In comparison to other methacrylates, pDMAEMA 
exhibits higher transfection rates and lower cytotoxicity, most likely due to the presence 
of protonizable tertiary amines (pKa 7.5).
55
 Studies show that primary and secondary 
amines are mainly responsible for high degrees of cytotoxicity, while polymers with 
tertiary amines are significantly less toxic but still transfectionally competent. 
Unfortunately, in vivo transfection of pDMAEMA is not as successful as in vitro studies. 
In ovarian cancer studies pDMAEMA has a 10% transfection efficiency in vitro, but only 





1.5.2    Bioreducible Polymers 
In an attempt to create safe and efficient delivery vectors, researchers have turned 
their focus to disulfide-containing polymers capable of responding to environmental 
stimuli.
24, 57, 58
 Disulfides (-S-S-) are formed by thiols (S-H) in an oxidation reaction. 
These linkages are relatively stable within the oxidizing extracellular environment of the 
cells, but are readily reduced back into thiols in the reducing intracellular environment of 
cells.
58
 As a result, thiol-containing polyplexes not only exhibit higher complex stability 
under extracellular conditions, but also have greater intracellular cargo release and lower 
cytotoxicity than non-thiolated carriers.
15, 57
 Previously, disulfide bonds have been used 
to link non-toxic low molecular weight (LMW) polymer units to develop biocompatible 
high molecular weight (HMW) carriers.
24
 Disulfide bonds have also been used to 




Studies have demonstrated that complexes formed by HMW polymers have higher 
transfection efficiencies and greater steric stabilization than LMW polyplexes, but also 
impart greater cytoxicities.
41-46
 Several explanations have been given as to why HMW 
polymers have greater transfection efficiencies. Van de Watering et al. proposed that the 
smaller polyplex size formed by HMW polymers is more conducive to internalization.
45
 
Godbey et al. suggested that HMW polymers are more capable of protecting genetic 
cargo from nucleases.
43
 Finally, Georgiou et al. explained that larger polymers can 
destabilize the cellular membrane more effectively than smaller polymers, thereby 
facilitating internalization.
44
 It is possible that membrane destabilization not only leads to 
greater transfection efficiencies, but also cell death. Pafiti et al. suggested that the 
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accumulation of HMW polymers at the cellular membrane leads to localized membrane 
destabilization and decreased cell viability.
46
 The effect of HMW polymeric carriers has 
been demonstrated in both linear and star polymers.
43, 44, 46
 To achieve the high 
transfection efficiency levels of HMW polymers while maintaining the relative safety of 
LMW polymers, researchers have developed bioreducible polymers, which primarily 
possess disulfide linkages in their backbone.
24
 Disulfide bonds are relatively stable in the 
oxidizing extracellular space, allowing bioreducible polymers to maintain polyplex 
structure and stability.
24, 58
 Within the reducing intracellular compartments, the disulfide 
bonds are reduced back into thiols and the polymer degrades into its LMW biocompatible 
segments. It is expected than that bioreducible polyplexes can achieve the high 




Disulfide bonds can also be used to increase polyplex stability by linking cationic 
polymers with hydrophilic, non-ionic polymers such as poly(ethylene)glycol (PEG) and 
N-(2-hydroxypropyl) methacrylamide (HMPA).
24
 Polyplex stability depends on polymer 
structure and N/P ratio, or polyplex charge.
32
 In vivo, cationic polymers electrostatically 
interact with negatively charged serum proteins, resulting in polyplex destabilization and 
rapid clearance by the phagocytic cells of the MPS.
2, 23
 It is therefore useful to avoid 
polymer-protein interactions by masking the polymers cationic charge with non-ionic 
polymers such as PEG and HMPA.
23
 This can be achieved by linking hydrophilic 
polymer segments onto a cationic polymer via disulfide linkages.
2, 24
 Studies have shown 
PEGylated polyplexes to have lower toxicity levels and prolonged circulation times in 






2. 1    Abstract 
Previous studies have focused on incorporating disulfide linkages either within the 
polymer backbone, or as direct linkages between cationic and non-ionic polymers in 
order to increase biocompatibility and serum stability. However, the potential of disulfide 
crosslinks extending from the polymer chain as a means of improving DNA binding 
efficiency, complex stability, and gene release has not been explored. Using 
poly(allylamine) (PAA) as a model, we investigated how pH sensitive disulfide 
crosslinked polymer networks can improve the delivery potential of cationic polymer 
carriers. To accomplish this, we conjugated thiol-terminated pendant chains onto the 
primary amines of PAA using 2-iminothiolane, developing three new polymer vectors 
with 5%, 13%, or 20% thiol modification. Polymer synthesis was verified by 5,5'-
dithiobis-(2-nitrobenzoic acid) (DNTB, Ellman’s Reagent) and H 
1
NMR. Polymer 
fluorescence was determined by UV plate readings. Complex size and stability was 
measured by dynamic light scattering (DLS) and zeta potential, respectively. Extent of 
disulfide formation and buffering capacity were demonstrated by DAPI assay. Cargo 






2.2    Experimental 
2.2.1    Materials 
Poly(allylamine) solution (PAA; MW 15000) was purchased from PolySciences Inc. 
2-Iminothiolane (2-IT, Traut’s reagent) and 5,5′-dithiobis-(2-nitrobenzoic acid) (DNTB; 
Ellman’s reagent) were purchased from Thermo Scientific. Millipore-Amicon Centrifugal 
Filter Units (MW cutoff of 5000 Da) were purchased from Millipore. pEGFP-N1 (4700 
base pairs) was donated by the Dr. Bentley Research Group at the University of 
Maryland who acquired the plasmid from CLONTECH Laboratories and cloned it with 
Top 10 competent cells from Invitrogen. Extractions were carried out by HiSpeed 
Plasmid Maxi Kit purchased from Qiagen. Ethidium bromide and 
ethylenediaminetetraacetic acid powder (EDTA) were purchased from Fisher Scientific. 
Heparin sodium salt, phosphate-buffered saline (PBS), pH 7.4, molecular grade, 4′,6-
diamidino-2-phenylindole (DAPI), DNase I amplification grade, hydrochloric acid (HCl), 
and sodium hydroxide (NaOH) were purchased from Sigma. A 1kb DNA Ladder, 10X 
TAE, and agarose were purchased from New England Biolabs, Promega, and Research 
Products International Corp, respectively. Folded capillary cells and stoppers were 






2.2.2    Methods 
2.2.2.1    Synthesis of Thiol-PAA 
Thiolation of cationic PAA is described in Figure 8. Briefly, PAA was dissolved in 4 
mL of PBS, pH 7.4, with 1.75 mg/mL EDTA and reacted with 0.375, 0.75, or 1.5 mg/mL 
2-iminothiolane (2-IT) so that 5, 13, or 20% of PAA’s primary amines were replaced 
with thiol-pendant chains. EDTA does not take part in the thiolation reaction but was 
used to chelate divalent metals in solution, thereby preventing thiol oxidation. The 
reaction was run at room temperature (RT) for 2 h with continuous shaking on a tabletop 
orbital shaker. After 2 h, samples were washed twice with PBS using Millipore-Amicon 
Centrifugal Filter Units. Centrifugation was carried out at 8000g. Washed samples were 
resuspended in PBS and stored at −80 °C. 
Thiolated polymers were characterized by 
1
H NMR in D2O. Degree of thiolation was 
quantified by a 5,5′-dithiobis-(2-nitrobenzoic acid) (DNTB, Ellman’s reagent) assay and 
verified by 
1
H NMR. The DNTB assay was prepared according to manufacturer protocol. 
Ellman’s reagent has been previously used to quantify thiol concentration on thiolated 
polymers.
60
 Briefly, 72 μg polymer was suspended in 1 mL of Ellman’s buffer with 50 
μL of DNTB reagent (2 mg/mL). The absorbance of the polymer solution was measured 
at 412 nm and the thiol concentration was determined by solving for c = A ÷ bE, 
where A is the absorbance at 412 nm, b is the path length in centimeters, E is the molar 





2.2.2.2    Polyplex Preparation  
pEGFP-N1 plasmid (MW 2.9 × 10
6
 Da, 4700 base pairs) was extracted from E. 
coli using the HiSpeed Plasmid Maxi Kit by Qiagen according to kit protocol. pEGFP-N1 
is commonly used in delivery studies because it expresses green fluorescent protein 
(GFP) only upon successful transfection, which is easily detected by UV and fluorescent 
microscopy. 
Polymer–plasmid complexation was carried out by incubating the polymer and 
plasmid at RT for 45 min at N/P ratios of 1, 5, 10, 20, and 40. The extent of disulfide 
formation in polyplexes was tested by measuring the concentration of reactive thiols 
present in solution at initial mixing and after the 45 min incubation period using the 
previously described DNTB assay. 
2.2.2.3    DNA Binding Efficiency 
A DAPI displacement assay was used to determine how thiol crosslinks affect the 
DNA binding efficiency of cationic polymers. Briefly, DAPI was added to pEGFP 
plasmid and incubated at RT for 30 min to allow the DAPI stain to intercalate into the 
plasmid strands. For complexation, polymers and DAPI-stained plasmid were mixed and 
incubated in a 96 well plate at N/P ratios of 1, 5, 10, 20, and 40. Each well consisted of 1 
g plasmid and was brought to a total volume of 100 l with PBS. Complexation was 
carried out at RT for 45 min. Fluorescence was read at ex= 360 nm and em= 455 nm. 
Relative fluorescence was determined using the following equation: 





Where Fpol  is the fluorescence of the polymer-plasmid/DAPI solution, FDNA is the 
fluorescence of DAPI complexed with plasmid, and Fo is the fluorescence of 
uncomplexed DAPI.  
Polyplex formation was further verified by gel electrophoresis. The electrostatic 
interactions between polymers and plasmid neutralize the DNA’s negative charge and 
polyplex migration down the agarose gel is retarded.
48
 Polymer-plasmid complexation 
was carried out in PBS as previously described under “Polyplex Preparation.”  Gels were 
composed of 0.7% agarose and contained ethidium bromide (EtBr). Polyplexes were run 
at 100 V for 1 h against a 1 kb ladder and a plasmid control. A second gel 
electrophoresis, in which polymer and plasmid were complexed in the presence of 4 
mg/mL heparin, was also performed for comparison purposes. Heparin is a negatively 
charged polysaccharide used to mimic in vivo interactions between cationic polymers and 
negatively charged proteins proteins.
62
  
2.2.2.4    Polyplex Size and Zeta Potential 
To determine polyplex size, polymer and pEGFP-N1 were complexed in 2 mL 
deionized water at N/P ratios of 1, 5, 10, 20, and 40. Hydrodynamic size measurements of 
polymer-plasmid complexes were obtained by dynamic light scattering (DLS). The 
hydrodynamic radius measured by the DLS is calculated from the Stokes-Einstein 
equation, RhkTD 6 where k  is the Boltzmann constant, T  is the temperature, 
  is the medium viscosity, and  f = Rh6  is the frictional coefficient for a hard sphere 
in a viscous medium.
63
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For zeta potential measurements, polymer-plasmid solutions were prepared at N/P 
ratios of 1, 5, 10, 20, and 40 in 0.8 mL deionized water. Zeta potential measurements 
were performed using a Malvern Zetasizer Nano ZS 90 particle analyzer.  
2.2.2.5    Serum Stability 
Gel electrophoresis was used to determine polyplex stability under in vivo mimicking 
conditions. Briefly, polymer-plasmid complexes were incubated in PBS, pH 7.4 for 45 
min at RT for complexation to occur. After the initial complexation time, heparin was 
added to the polyplex solution at a final volume of 4 mg/mL heparin and the polyplexes 
were incubated for another 30 min at RT. Complexes were then run on a 0.7% agarose 
gel containing EtBr against a 1 kb ladder and a plasmid control for 1 h at 100 V.  
2.2.2.6    DNase Protection Assay 
A DNase I protection assay was performed to determine the DNA protection potential 
of thiolated polymers relative to the unmodified polymer. Briefly, polymer-plasmid 
complexation was carried out in PBS as previously described. Polyplexes were 
subsequently added to a solution of 4 mg/mL heparin containing 0.1 unit/l DNase 




 unit/l enzyme activity) to mimic in 
vivo conditions.
64






2.2.2.7    Buffering Capacity  
A polymeric carrier’s buffering capacity can affect its potential for endolysosomal 
escape and its delivery success.
65
 Buffering capacity is defined as the percentage of 
positively charged groups that become protonated from pH 7.5-5.1.
66
 It can be 
determined with an acid-base titration assay. Briefly, unmodified, 5%, 13%, and 20% 
thiol-modified polymers were added to 150 mM NaCl solution at a concentration of 0.2 
mg/mL and the solutions were brought to a pH~11 with NaOH. Then, 0.1 M HCl was 
added to polymer solutions in increments of 25 l and the pH was measured at each 
point. The buffering capacity was calculated using the following equation: 
Buffering capacity (%)= (VHCl x 0.1M)/N(mmol)* 100 
66
 
Where VHCl is the volume of the HCl solution (mL) needed to bring the pH from 7.4 
to 5.1, 0.1 M is the concentration of the HCl, and N (mmol) is the total moles of polymer 
amines in each titration. 
2.2.2.8    pH-Sensitive Gene Release 
A DAPI assay was used to assess the polymer’s potential to release the DNA cargo 
within the acidic environment of the cell. Briefly, polymer and plasmid were complexed 
at N/P ratios of 1, 5, 10, 20, and 40. Polyplex solutions were then brought to a pH of ~5.5 
(late endosomal pH) using 0.1 M HCl and incubated for 30 min to allow for plasmid 
release. After the initial incubation period, DAPI was added to the solutions which were 
then incubated for an additional 30 min period. DAPI fluorescence was read at ex= 360 
nm and em= 455 nm. 
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2.2.2.9    Statistical Analysis  
All experiments were performed in triplicate. Data is presented as the average and 
corresponding standard deviation (error bar) of three (n = 3) separate sample trials. For 
zeta potential and DLS runs, multiple values were collected from each sample and 













2.3    Results and Discussion 
2.3.1    Characterization of Thiolated Polymers 
Using PAA as a model for a cationic polymer delivery vector, our goal was to 
improve the delivery potential of cationic polymers by generating pH-sensitive disulfide 
crosslinked modifications. By altering the concentration of 2-IT used in the synthesis 
reaction, we synthesized three thiolated polymers with 5, 13, or 20% thiol conjugation 
(Figure 8). The thiol percentage is a measure of how many primary amines on the PAA 
backbone were successfully conjugated with thiol-pendant chains. Thiolation was 
verified and quantified by a DNTB assay and by 
1
H NMR.  
According to the DNTB assay, 0.375, 0.75, and 1.5 mg/mL 2-IT synthesizes 5, 13, 
and 20% thiolated polymers, respectively (Table 1). 
1
H NMR was performed on 
unmodified and 20% thiol-modified polymer in D2O to verify thiolation. In the 
unmodified polymer, the methyl peak, adjacent to the primary amine, is located at 3.5 
ppm. Thiol conjugation results in the formation of an additional peak at 2.6 ppm which 
signifies the presence of the methyl group adjacent to the thiol. An integration of the 
relative area under these two peaks verifies that the approximate 20% thiolation 








Figure 8. Synthesis of thiolated polymer by 2-iminothiolane 
 
 








1 1 0 0 
2 1 0.375 4.59 ± 2.43 
3 1 0.75 13.07 ± 1.61 







2.3.2    Validation of Disulfide Bonding 
Other studies have shown that thiol conjugates can readily form crosslinked disulfide 
networks. PEGylated peptides can condense DNA through ionic interactions, as well as 
crosslinked networks formed by the spontaneous oxidation of cysteine thiols.
24
  
Correlations between disulfide formation and solution viscosity indicate that thiol 
oxidation occurs more rapidly in viscous solutions. It is presumed that the close 
proximity of thiols in viscous solutions facilitates disulfide bonding.
60
  
Table 2 shows the percent of free thiols present in solution after the 45 min 
incubation period as determined by DNTB. For 5% and 13% polymers, the general trend 
showed that the percentage of free thiols decreased, and therefore the number of 
disulfides increased, with increasing N/P ratio. We believe that increased disulfide 
bonding in higher N/P complexes resulted from the close proximity of thiols, as 
previously suggested by Maraschutz et al.
60
 Overall, 5% thiolated polymers exhibited the 
highest degrees disulfide formation, followed by the 13% thiolated polymers. The 
exception was the N/P 40, 13% polyplexes which achieved the highest degree of 
crosslinking among all polyplexes. Interestingly, 20% thiolated polymers achieved very 
low disulfide binding. We believe that the additional amines from 2-IT increased the 
polymer’s cationic charge, leading to greater repulsion among polymer chains and 





Table 2. Percentage of thiols present in solutions after polymer-plasmid complexation  
 
N/P 5% Thiol 13% Thiol 20%Thiol 
1 97.19 ± 0.97 90.14 ± 3.90  91.32 ± 3.85 
5 77.66 ± 0.76 90.39 ± 2.13 84.10 ± 6.95  
10 52.26 ± 0.52 74.94 ± 3.43 55.37 ± 19.5 
20 55.66 ± 0.48 66.54 ± 2.44  87.90 ± 6.46 















2.3.3    DNA Binding Efficiency 
Cationic polymers bind their genetic cargo through electrostatic interactions between 
the positively charged amines of the polymer and the negatively charged phosphates of 
the DNA backbone. The amines of a polymer backbone, however, have been linked to 
high cytotoxicity.
39, 67
 Therefore, it would be beneficial to develop a carrier that can carry 
larger amounts of DNA cargo at lower polymer concentrations. To determine whether 
thiol crosslinks can increase the amount of genetic cargo held by each carrier, the binding 
efficiencies of the unmodified and thiol-modified polymers were assessed using a DAPI 
displacement assay. DAPI is a fluorescent probe that interacts strongly with A-T base 
pairs of DNA. When bound to DNA, DAPI displays intense fluorescence at ex/em 
~360/455 nm. The electrostatic interaction and complexation between polymer and DNA 
displaces DAPI and decreases fluorescence intensity. Hence, as DAPI fluorescence 
decreases, the polymer binding efficiency increases.
61
  
The effect that thiolation and polymer concentration have on the fluorescence of 
DAPI-DNA is represented in Figure 9. Unmodified PAA had the least effect on 
fluorescence across all N/P ratios, suggesting weak PAA-DNA binding. This result was 
confirmed by gel electrophoresis on an agarose gel containing EtBr. Like DAPI, EtBr is 
an intercalating dye that only binds to free DNA, or DNA that is not complexed with 
polymer. As a result, only free DNA is visible by gel electrophoresis.
68
 The gel assay 
demonstrated that PAA cannot adequately bind DNA cargo (Figure 10). PAA is a weak 
polyelectrolyte that has previously been shown to exhibit aggregation properties 
dependent on concentration, environmental pH, and aging times.
69
 In a study by Zhou et 
al.,
70
 discrete nanoparticles between PAA and DNA were formed at N/P values between 
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0.8-1.0, as determined by changes in light scattering. Further analysis by an EtBr 
displacement assay showed that at N/P ratios between 0.67 and 1.0 PAA decreased EtBr-
DNA interactions, confirming some complexation. However, increasing the N/P ratio 
from 1.0 to 1.67 had no affect EtBr-DNA binding. Zhou et al.
70
 concluded that at higher 
PAA concentrations EtBr-DNA interactions are independent of changes in the polymer 
concentration. In another study, Pathak et al.
48
 demonstrated that PAA-DNA 
complexation occurs only at very high polymer concentrations. This was done by running 
PAA-DNA complexes with polymer/plasmid weight ratios of 0.1, 0.2, and 0.3 g/g on 
an agorose gel. According to the data, polyplex retardation occurred only at the highest 
polymer concentration, which is nearly 10-fold higher than that of our N/P 40 complexes.  
Thiolation improves the polymer’s ability to displace DAPI and bind with plasmid 
DNA. According to Figure 9, all thiolated polymers demonstrated greater efficiency in 
displacing DAPI than PAA across all N/P ratios. When 5%, 13%, and 20% thiolated 
polymer concentrations are increased from N/P 1 to N/P 5, there is a sharp decrease in 
DAPI fluorescence. At N/P 10, DAPI fluorescence drops to values as low as ~40 a.u. for 
all thiolated polymers. At N/P 20 and 40, DAPI fluorescence intensity is maintained 
between ~35-45 a.u. This suggests that past N/P 10 polymer-DNA binding is not greatly 
affected by the increasing polymer concentration.  
Gel electrophoresis yielded similar results. While PAA complexes exhibited no 
retardation, migration of thiolated polyplexes was impeded at high N/P ratios. As seen on 
Figure 10, thiolated polymers could not complex DNA at N/P 1 regardless of percent 
thiolation. Referring to the DAPI results (Figure 9), we see that at N/P 1, even the highly 
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thiolated 20% polymer decreases fluoresce by only 20 a.u. with respect to the unmodified 
polymer. All thiolated polymers exhibited minimal crosslinking at N/P 1 (Table 2), which 
could potentially explain why complexation was unsuccessful. At higher N/P ratios, 
thiolated polyplexes exhibited either partial or complete complexation. Partial 
complexation was evident by a faded plasmid strand, which suggests that only some of 
the DNA migrated through the gel. For some polyplexes, the DAPI assay and gel 
electrophoresis showed conflicting results. For example, the 20% thiolated polymer 
displaced DAPI just as efficiently at N/P 5 as it did at N/P 40. However, at N/P 5, 20% 
thiolated polymers did not completely retard plasmid migration, whereas N/P 40 
complexes did. We believe that the low DAPI fluorescence of 20% thiolated complexes 
can be attributed to the large size of the polymer. It is possible that the larger chain 
density of 20% thiolated polymers sterically hinders DAPI-plasmid interaction, thereby 
decreasing DAPI fluorescence. At the same time, the greater degree of disulfide 
crosslinks in 5% and 13% thiolated complexes (Table 2) may have prevented plasmid 
migration along the gel.   
Polymer-plasmid complexation was also performed in the presence of heparin to 
determine whether the negative charge of heparin would inhibit complexation. Resulting 
gel assays showed that in the presence of heparin, neither PAA nor thiolated polymers 
can complex DNA (Figure 11). The strong negative charge of heparin inhibited the 






Figure 9. Displacement of DAPI from pEGFP-N1 by unmodified and thiolated polymers shows that 
thiolated polymers displaced DAPI more efficiently than unthiolated PAA, suggesting greater DNA 




Figure 10. Gel electrophoresis of PAA (A), 5% (B), 13% (C), and 20% (D) thiol-polyplexes 
complexed in PBS indicate that PAA does not adequately package DN, whereas all thiolatd polymers 




Figure 11. Gel electrophoresis of PAA (A), 5% (B), 13% (C), and 20% (D) thiol-polyplexes 








2.3.4    Complex Size and Stability 
Formation of stable, nanosized polyplexes is an important prerequisite for successful 
cellular internalization. Optimal complex size varies between cell types, but spherical 
particles of ~100 nm are more amenable for internalization in cell culture and in vivo.
71
 
Polyplex stability, or the complex’s ability to resist aggregation, also plays a vital role in 
successful gene delivery. Polyplex aggregation results in particles that are too large for 
efficient cellular uptake. In addition, polymer aggregates that accumulate at the cell 
surface can damage the plasma membrane. In vivo, polyplex aggregation prevents cargo 




Polyplex size and stability were determined using dynamic light scattering (DLS) and 
zeta potential, respectively. The magnitude of the zeta potential indicates the stability of a 
colloidal system. Large negative or positive zeta potentials indicate that the particles 
repel each other. Repulsion limits particle aggregation and allows for a stable suspension 
to form. Generally, zeta potentials greater than +30 mV or lower than -30 mV indicate 
good stablity. As zeta potentials approache zero, particles in suspension aggregate.
73
 
DLS data (Table 3) showed no consistent pattern for 5%, 13%, and unmodified 
polymer complexes. The size of unmodified PAA and 5% thiolated PAA polyplexes 
could not be determined at N/P 1 and N/P 5 due to large fluctuations in complex size. 
Based on the low zeta potentials corresponding to unmodified and 5% thiolated polymers 
at N/P 5, we believe the large polydispersity of these complexes results from complex 
instability. However, at N/P 1 both unmodified and 5% thiolated polymers have zeta 
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potentials that are quite negative and thereby do not support the DLS data. The smallest 
complexes were formed by N/P 10-40, 5% polyplexes, which can be explained by the 
high degree of crosslinking in these polyplexes. 13% and 20% thiolated polymers show 
more consistency between DLS and zeta potential measurements than the unmodified and 
5% thiolated polymers. At N/P ratios of 1, 20, and 40, 13% thiolated polymers formed 
polyplexes of ~100 nm with a small standard deviation. N/P 5, 13% polyplexes, on the 
other hand exhibited a large size range which can be explained by the low zeta potential 
of these complexes. The exception to this set of polyplexes were the N/P 10 complexes 
which were nearly twice as large in size. Finally, the 20% thiolated polymers showed the 
greatest consistency between DLS and zeta potential data. Complexes obtained from the 
20% thiol-modified polymer reached absolute zeta potential values between 25 and 40 
mV, and ranged between 80-125 nm. Since 20% thiolated polymers did not demonstrate 
high degrees of thiol crosslinking, we believe that polyplex formation resulted primarily 









Table 3. Polyplex size and zeta potenials 
% thiol N/P Size (nm) (mV)
0 1 - -20.00 ± 2.07 
0 5 - -6.75 ± 3.24 
0 10 122.50 ±33.45 4.74 ± 4.47 
0 20 100.85 ± 21.88 10.75 ± 3.07 
0 40 105.48 ± 7.55 16.00 ± 0.53 
5% 1 - -27.53 ± 1.16 
5% 5 - -15.68 ± 5.63 
5% 10 63.05 ± 23.22 11.36 ± 3.79 
5% 20 71.45 ± 20.09 17.83 ± 1.63 
5% 40 91.63 ± 14.03 19.73 ± 0.21 
13% 1 104.05 ± 5.72 -34.00 ± 1.87 
13% 5 91.94 ± 48.51 4.26 ± 0.52 
13% 10 191.85 ± 24.17 35.90 ± 1.25 
13% 20 100.56 ± 8.98 38.23 ± 0.75 
13% 40 105.05 ± 4.80 41.77 ± 2.67 
   -35.37 ± 1.07 
20% 1 80.76 ± 10.01 
20% 5 87.72 ± 7.95 24.13 ± 2.76 
20% 10 99.72 ± 5.02 31.87 ± 2.82 
20% 20 117.61 ± 5.25 38.87 ± 5.79 










2.3.5    Heparin-Induced Decomplexation 
Typically, in vitro polymeric gene delivery assays are carried out in serum free 
medium to avoid the polymer-protein interactions that inhibit polyplex internalization. In 
vivo, however, cationic polymer-protein interactions cannot be avoided. Negatively 
charged serum proteins aggregate around polymer-plasmid complexes. As a result, 
polyplexes are destabilized, and the DNA is left susceptible to enzymatic degradation. 
Hence, we evaluated the polymers potential to maintain complex stability in a more 
physiologically-relevant system, e.g., in the presence of heparin, a negatively charged 
polysaccharide used to mimic potential polyplex interactions with serum proteins.
62
 
Thiolated polymers were complexed in PBS, then exposed to heparin for 30 min, and 
finally run on an agarose gel to evaluate the degree of decomplexation. Figure 12 shows 
that thiolated polymers decomplexed at low N/P ratios but remained intact at higher N/P 
ratios. 5% and 20% thiolated polymers maintained polyplex stability at N/P ratios of 10, 
20, and 40, decomplexing only at N/P 1 and 5. The 13% thiolated polyplxes decomplexed 
only at N/P 1. Unmodified PAA showed complete decomplexation. However, from the 
complexation assay (Figure 10), we know that PAA never complexed with plasmid. 
Further, when comparing the complexation and decomplexation assays, it becomes 
evident that polyplexes that were only partially complexed in the complexation assay 
(Figure 10) completely decomplexed in the presence of heparin (Figure 12). From the 
data, it appears that overall the 13% thiolated polymer would be a better carrier choice for 




Figure 12. Gel electrophoresis of unmodified PAA (A), 5% (B), 13% (C), and 20% (D) thiol-
polyplexes after suspension in a heparin solution. Results indicate that all thiolated polymers were 










2.3.6    Cargo Protection 
For a polymeric delivery vector to be clinically successful, it must not only bind 
DNA, but must also protect the cargo from degradative enzymes present in the host 
circulatory system. Results obtained from the heparin induced decomplexation assay 
suggested that at higher N/P ratios thiolated polymers have the ability to maintain 
polyplex structure in the presence of serum proteins. These polymers should therefore 
also be more efficient at protecting gene cargo than unmodified polymer carriers. To 
determine whether thiol crosslinks improve gene  protection, a DNase I protection assay 





enzyme activity. To mimic these conditions, polyplexes were complexed in plasmid, then 
added to a heparin solution, and finally treated with 0.1 unit/l DNase I.
64
 Samples were 
subsequently run on a 0.7% agarose gel to determine DNA degradation. 
Results showed that weakly bound PAA (Figure 13) could not protect plasmid from 
DNase degradation across all N/P ratios. Thiolated polymers, on the other hand, 
successfully protected the plasmid at N/P ratios of 20 and 40, but left the plasmid 
susceptible to degradation at lower N/P ratios. The 20% thiolated polyplexes completely 
degraded at N/P 1, 5, and 10, which could potentially be explained by the poor disulfide-
linking of these polyplexes. 5% and 13% thiolated polymers, performed better than the 
20% complexes, exhibiting only partial plasmid degradation. Partial degradation is 
evident by the presence of two bands, a degraded DNA band and an intact DNA band. 
The 13% thiolated polymers showed some enzymatic degradation at N/P 1-20, but 
completely protected the DNA with the highly crosslinked N/P 40 polyplexes. The 5% 
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thiolated polyplexes exhibited partial degradation across all N/P ratios. It is possible that 
the greater enzymatic protection in 5% and 13% polyplexes resulted from the higher 
degree of disulfide crosslinking. 
When comparing the data aquired from the “Heparin-Induced Decomplexation” assay 
and the “DNase I Protection Assay”, it becomes evident that some samples which resisted 
decomplexation in the presence of heparin, did not completely protect the DNA cargo in 
the DNase I assay. For example, 13% thiolated polyplexes with N/P>5 remained intact in 
the presence of heparin (Figure 12c). Based on this data, it could be inferred that these 
complexes would completely resist DNase I degradation. However, Figure 13c shows 
partial DNA degradation in these samples. We believe that heparin-polymer interactions 
were not strong enough to completely decomplex polyplexes and release plasmid cargo, 
but that the presence of heparin was sufficient to destabilize complexes leaving some of 




Figure 13. Gel electrophoresis of unmodified PAA (A), 5 (B), 13% (C), and 20% (D) thiol-polyplexes 
after exposure to DNase I in a heparin solution. Results show that PAA could not protect plasmid 










2.3.7    Buffering Capacity and Endolysosomal Escape 
Due to size restrictions, polyplexes typically cannot diffuse into cells and must be 
taken up by endocytosis, a multistep process in which cells internalize molecules from 
the extracellular space by engulfing them within the cell membrane. A portion of the 
membrane invaginates and pinches off from the cell forming a membrane bound vesicle 
known as the endosome. Upon internalization, the endosome has a pH ~7 which 
ultimately drops to pH~4 as the vesicle matures from an endosome to a lysosome.
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Polyplexes that do not escape the endolysosome are eventually degraded. Although more 
than 95% of cells in a culture internalize polyplexes during a given transfection, less than 
50% of cells express the gene.
2
 From this standpoint, a polymers success is dependent 
upon its ability to buffer the endolysosomal pH, which has been shown to facilitate 
polyplex escape into the cell cytosol via the proton-sponge effect.
2, 13
 To determine 
whether thiol groups can improve the buffering capacity of cationic polymers, we 
performed a titration assay in which 0.1 M HCl was added to polymer solutions in 
increments of 25 l and the change in pH was recorded. Polymers with a high buffering 
capacity contain larger amounts of protonizable groups. As a result of this buffering 
effect, a greater amount of protons, or acid, must be added to the solution for the pH to 
drop. Since disulfides are readily reduced in the presence of protons, increasing the 
number of thiols conjugated onto the polymer backbone improves the polymers buffering 
capacity. Each polymer’s buffering capacity was calculated as the percentage of amine 
groups being protonated when the pH drops from pH 7.0 to 5.1, conditions mimicking the 
change from the extracellular environment to the low pH of the endosome.
66
 The results 
showed that the presence of thiols can drastically improve the polymers buffering 
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capacity. 20% thiolated polymers had a buffering capacity of ~47%, which was more 
than double the buffering capacity of unmodified polymer (~19%). The 5% and 13% 
polymers attained buffering capacities of ~30 and ~36, respectively. The improvement in 
buffering capacity is evident in the titration curves obtained (Figure 14). 
 
 
Figure 14. Titration assay of unmodified PAA, 5, 13, and 20% thiolated polymers shows that 







2.3.8    pH-Sensitive Gene Release 
Polymeric carriers that depend solely on strong electrostatic interactions to bind gene 
cargo often experience inefficient cargo release; the polymer remains bound to the DNA 
even within the cell. As a result, the delivered DNA never reaches the nucleus where 
gene expression takes place. The binding efficiency studies showed that at higher N/P 
ratios thiolated polymers were able to successfully complex DNA. A pH-sensitive gene 
release assay was performed to determine whether thiolated polymer could release its 
cargo within the endosome before reaching lysosomal degradation. Figure 15 shows the 
relative fluorescence of DAPI-labeled DNA of unmodified and thiolated polyplexes at 
N/P ratios of 1, 5, 10, 20, and 40. At endosomal pH 5.5, unmodified and 5% thiolated 
polymers showed very low (if any) gene release. The high fluorescence intensities 
observed in the unmodified polyplex solutions once again verified that PAA does not 
adequately bind DNA. 5% thiolated polyplexes, on the other hand, exhibited low 
fluorescence intensities at pH 7.0, suggesting high binding efficiency. The previous DAPI 
displacement and gel assays demonstrated that the 5% thiolated polymer was the most 
efficient at binding DNA. This data verified that result and also showed that 5% 
polyplexes did not adequately release DNA; polymer-plasmid complexes remained 
bound even at the low pH of 5.5. The 20% thiol polyplexes exhibited high cargo binding 
and release only at N/P ratios of 20 and 40. At N/P 1, 5, and 10, 20% thiolated polymers 
did not appear to sufficiently bind cargo DNA. This result can also be seen in the gel 
assay (Figure 10). Finally, the 13% polymer appeared to have the highest binding-release 
capabilities out of all thiolated polymers, with the N/P 40 ratio being the exception. As 
demonstrated by the DNTB assay, 13%, N/P 5 polyplexes displayed the greatest amount 
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of crosslinking amongst all polymer samples. Based on this data it can be inferred that an 
optimal combination of charge ratio and thiol crosslinks are required for high binding and 
release kinetics.  
 
 
Figure 15. pH-sensitive plasmid release determined by a DAPI dispacement assay. Results show that 
13% (NP 1-40) and 20% (NP 20-40) polyplex formulations were most efficient at binding DNA at pH 







Our data demonstrates that a certain degree of thiolation can significantly improve the 
carrier’s in vivo potential. From our results we can conclude that the 5% thiolated 
complexes would be inefficient polymeric carriers because of their low gene release. 
Although these complexes bind and protect DNA more efficiently than 13% and 20% 
thiolated polymers, they exhibit minimal (if any) gene release at endosomal pH. 5% 
thiolated polyplexes also demonstrated the greatest amount of crosslinking overall. We 
therefore believe that too many crosslinks hinder the polymer’s delivery potential. At the 
same time, the 20% thiolated polymer, which had the greatest buffering capacity and 
potential for endolysosomal escape, was also inefficient at DNA binding and release. 
Further, 20% thiolated polymers were the least effective in protecting gene cargo. The 
N/P 20 and 40, 20% thiolated polyplexes were the exception to the 20% polyplex 
formulations, exhibiting high binding and release kinetics. Therefore, the polyplexes with 
the greatest delivery potential overall, were the 13% thiolated polymers. Although 13% 
polyplexes showed partial degradation in the presence of DNase, they also achieved 
approximately twice the buffering capacity of PAA and were typically better at binding 








3.1    Abstract 
This study investigates the extent of disulfide linking in a thiol-containing polymer 
and determines the impact that free thiols have on the polymer’s delivery potential. A 
fluorescent cationic polymer containing thiol-pendant chains was prepared from 
poly(allylamine) (PAA) and 2-iminothiolate (Traut’s Reagent) as described in chapter 2. 
Polymer fluorescence was determined by UV plate readings. Complex size and stability 
was measured by dynamic light scattering (DLS) and zeta potential, respectively. 
Transfection efficiency and cytotoxicity were assessed in MCF-7 breast cancer cells. 
Results show that polymers containing thiol crosslinks form smaller, more stable 
complexes than non-thiolated PAA. Fluorescent measurements, microscopy imaging, and 
DNA electrophoresis show that thiolated polymers are not internalized by cells in a 
culture, yet, they bind to the cell surface, perhaps valuable for applications requiring cell 
adhesion. Therefore, the extent of disulfide formation in thiolated polymers must be 







3.2    Experimental 
3.2.1    Materials 
Poly(allylamine) solution (PAA) (MW 15000) was purchased from PolySciences Inc. 
2-iminothiolane (2-IT, Traut’s reagent) and 5,5'-dithiobis-(2-nitrobenzoic acid) (DNTB) ( 
Ellman’s reagent) were purchased from Thermo Scientific. Millipore-Amicon® 
Centrifugal Filter Units (MW cutoff of 5000 Da) were purchased from Millipore. The 
DNA plasmid pEGFP-N1 (4700 base pairs) was purchased from CLONTECH 
Laboratories and cloned with Top 10 competent cells from Invitrogen. MCF-7 cells (Cat 
No. HTB-22) were purchased from ATCC. Extractions were carried out by HiSpeed 
Plasmid Maxi Kit purchased from Qiagen. Ethidium bromide, ethylenediaminetetraacetic 
acid powder (EDTA), Texas red-dextran (MW 10,000), paraformaldehyde (PFA), cover-
slips, and glass slides purchased from Fisher Scientific. Dulbecco's Modified Eagle 
Medium and Lipofectamine2000 were purchased from Invitrogen. Phosphate buffered 
saline (PBS) molecular grade pH 7.4, 4',6-diamidino-2-phenylindole (DAPI), mowiol, 
filipin, amiloride, and monodansylcadaverine (MDC) were purchased from Sigma. 
Trypsin and penicillin/streptomycin were acquired from Gibco. Fetal bovine serum (FBS) 
was purchased from Cellgro. 1kb DNA Ladder, 10X Tris-Acetate-EDTA buffer (TAE), 
and agarose were purchased from New England Biolabs, Promega, and Research 
Products International Corp, respectively. Folded capillary cells and stoppers were 




3.2.2.    Methods 
3.2.2.1    Polymer Synthesis and Complexation 
Thiolated polymers were synthesized and complexed with plasmid DNA as described 
in chapter 2. Briefly, PAA (MW 15,000) was dissolved in 4 ml PBS 4 at 1 mg/mL,with 
1.75 mg/mL EDTA, and 1.5 mg/mL 2-iminothiolane. The reaction was run at room 
temperature (RT) for 2 h with continuous stirring on table-top orbital shaker. Synthesized 
thiolated polymers were washed with PBS using Milipore-Amicon Centrifugal Filter 
Units and stored at -80
o
C. 
pEGFP-N1 plasmid (MW 2.9 x 10
6 
Da, 4700 base pairs) was extracted from E. coli 
using the HiSpeed Plasmid Maxi Kit by Qiagen according to kit protocol. Polymer-
plasmid complexation was carried out by incubating the polymer and plasmid at RT for 
45 min at N/P ratios of 1, 5, 10, 20, and 40. 
3.2.2.2    Polymer Fluorescence  
Thiolated and unthiolated polymer were added to 40 l PBS at concentrations of 
0.005, 0.025, 0.05, 0.10, and 0.20 mg/mL in a 96 well plate. These concentrations 
correspond to those used in polyplexes with N/P (nitrogen/phosphate) ratios of 1, 5, 10, 
20, and 40 delivered to MCF-7 cells. The fluorescence intensity of polymeric samples 
was measured with a plate reader at ex/em ~ 595/620 nm. A model red fluorescent 





3.2.2.3    Measuring GFP Expression  
Transfection efficiency of thiolated and non-thiolated polymers was determined by 
GFP expression. Briefly, MCF-7 cells were plated on gelatin coated cover-slips in 24-
well plates at 200,000 cells/well and incubated overnight in 1x Dulbecco’s Modified 
Eagle Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS) and 1% 
streptomycin/penicillin at 37
o
C for cell adherence. After 24 h, confluent cells were 
incubated for 4 h at 37
o
C in serum free media containing non-thiolated or 20% thiolated 
polyplexes with N/P ratios of 1, 5, 10, 20, and 40. Positive control cells were treated with 
commercial transfection reagent lipofectamine2000, according to supplier protocol. 
Negative control groups included untreated and plasmid (no polymer) treated cells. Cells 
were then washed and incubated in serum-supplemented DMEM for 48 h to allow for 
GFP expression. After 48 h, cells were washed, followed by staining with DAPI, cell 
fixation with 2% paraformaldehyde (PFA), and mounting on glass slides using Mowiol. 
Samples were visualized using an Olympus IX81 fluorescence microscope (Olympus) 
and a 40X objective. Fluorescent images were obtained with an ORCA-ER camera 
(Hamamatsu Corporation) and SlideBook™ 4.2 software (Intelligent Imaging 
Innovations, Inc.). Fluorescence images were analyzed using Image-Pro 6.3 software 
(Media Cybernetics, Inc). 
3.2.2.4    Gel Electrophoresis 
Gel electrophoresis was performed on DNA samples isolated from cell media and 
transfected cells to determine whether gene cargo was completely internalized. Briefly, 
cells were plated and transfected with thiolated polyplexes as described above. After the 
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4 h transfection period, media was collected from wells. Cells were collected with trypsin 
and plasmid and chromosomal DNA were extracted and purified with the PuregeneCore 
Kit (Qiagen) according to kit protocol. Plasmid that did not internalize was similarly 
purified from cell media. DNA samples were run at 100 V for 1 h on a .07% agarose gel 
containing ethidium bromide (EthBr) and loading dye, against a 1 kb ladder. 
3.2.2.5    Uptake Inhibition 
Filipin, amiloride, and MDC inhibit caveolae assisted internalization, 
macropinocytosis, and clathrin-mediated endocytosis, respectively.
74, 75
 To determine 
potential polyplex internalization by any of these pathways, cells were treated with 
filipin, amiloride, and MDC prior to transfection. MCF-7 cells were plated on gelatin 
coated cover-slips in 24-well plates at 200,000 cells/well and allowed to adhere 
overnight. The following day, cells were treated with filipin (1 g/ml), amiloride (3 mM), 
or MDC () for 30 min at 37
o
C as previously described.
76
 Then, N/P 40, 20% 
thiolated polyplexes were added and incubated for 4 h with inhibitors present. Control 
groups included untreated cells and cells treated only with polyplexes (no inhibitors). 
Post-transfection washing, staining, fixation, and visualization were carried out as 
described above. Polymer fluorescence intensities were calculated by analyzing the sum 
fluorescence intensity using Image-Pro 6.3 software. The average fluorescence intensity 
was then calculated by dividing the sum fluorescence intensity of each image by the 




3.2.2.6    Polymer-Cell Surface Binding 
Polymer-cell membrane interactions were studied by incubating cells with thiolated 
polyplexes or uncomplexed (no plasmid) thiolated polymers for 4 h as done in the above 
transfection assays. Cell preparations, transfections, and calculations for polymer 
fluorescence intensities were carried out as described above. Untreated cells were used as 
a control.  
To determine whether incubation time plays a role on polymer-cell binding, a time 
dependent transfection was performed. Polyplex internalization was determined by 
fluorescence microscopy. Cell plating and polyplex transfection were carried out as 
previously described. However, instead of the 4 h incubation period previously used, 
polyplexes were incubated with cells for 30 min, 1 h, 2 h, 4 h, and 24 h. At each of these 
times points, cells were washed, stained with DAPI, fixed, and mounted as described 
above. The average fluorescence intensities were calculated and compared to an untreated 
control group. 
Temperature effects on polymer-cell membrane binding were determined by 




C for 4 h. Cell preparation and transfections 
were carried out as previously described. After the 4 h incubation period, cells were 
washed, stained, fixed, mounted, and visualized as described above. The average 
fluorescence intensities were calculated and compared to untreated control cells 








3.2.2.7    Cell Count  
To determine the effects of thiol-pendant chains on cell viability, MCF-7 cells were 
transfected with non-thiolated PAA or 20% thiolated polyplexes at N/P ratios 1-40 as 
previously described. Control cells were treated with Lipofectamine2000 in order to 
assess polymer toxicity relative to a commercial reagent. Commercial surfactant Triton X 
was used as a positive cytotoxic control. Untreated cells were used as a negative control 
for toxicity. Gross cell viability was inferred by determining cell counts in the culture 48 
h post transfection. Ten images were obtained from each well; cell nuclei were counted 
and averaged. Cell count was calculated relative to untreated control cells. 
3.2.2.8    Statistical Analysis 
For all transfection assays, analysis was performed on ≥ 2 cover slips, using 10 
images per cover slip, and ≥ 40 cells per image. 
The data are expressed as the mean ± standard error of the mean (SEM). Outliers 
were identified using Grubb’s outlier test. The criterion for statistical significance 







3.3    Results and Discussion 
3.3.1    Polymer Fluorescence  
Figures 16 and 17 show the fluorescent intensities of unthiolated and thiolated PAA 
as measured by UV plate readings. Polymer fluorescence was tested at 5 different 
polymer concentrations and compared to a model fluorescently-labeled polymer, Texas 
red dextran, a positive control. As shown in Figure 16, unthiolated PAA did not 
demonstrate any photosensitivity at ex/em ~595/620 nm. Thiolated polymer on the other 
hand reached fluorescent intensities ~1000 a.u. We believe that the fluorescence of 
thiolated polymers resulted from interactions between the strongly nucleophilic thiolates 
and -electrons associated with the C=N. Literature shows that thiolates form in solution 
from thiols.
77
 Further, it is well documented that molecules containing ‘’ electrons (also 
known as delocalized electrons) or ‘lone pair’ electrons (particularly those associated 
with N, O, P, and S atoms) are capable of fluorescence.
78
 The fluorescent characteristics 




Figure 16. Fluorescence intensity of non-thiolated PAA, thiolated polymer, and Texas red dextran 
control determined by UV plate reader show that thiolated polymers exhibit a concentration 












3.3.2    Polyplex Delivery and GFP Expression 
PAA has been proven to be a poor gene delivery vector due the polymer’s low 
buffering capacity at endosomal pH.
48
 Unlike more efficient delivery vectors, such as 
poly(ethyleneimine) and poly(amidoamine) dendrimers, which possess titratable 
secondary and tertiary groups, PAA only contains non-titratable primary amines.
38, 48
 As 
a result, upon cellular internalization PAA cannot escape the endosome through the 
proton sponge effect: a phenomenon in which endosomal osmotic swelling, brought on 
by the presence of hydrolysable amine groups on the polymer, causes the endosome to 
rupture, releasing the polymer-DNA complexes into the cell cytosol.
48, 79
 
Previously we demonstrated that thiolated polymers efficiently complexed plasmid 
DNA, obtaining size values between 80-120 nm, whereas non-thiolated polymers were 
not as efficient at binding cargo. To determine whether thiol-pendant chains impact the 
transfection success of cationic polymers, transfection assays were performed in MCF-7 
breast cancer cells. Fluorescent images of MCF-7 cells treated with non-thiolated and 
thiolated polyplexes show that all polyplex treated cells and negative control groups did 
not express GFP. In contrast, positive control cells treated with commercial lipofectamine 
successfully expressed GFP. Figure 17, shows a set of fluorescent images collected from 
cells treated with 20% polyplexes at N/P ratios 1, 5, 10, 20, and 40, and control groups. 
The green fluorescence visible only in lipofectamine treated cells results from GFP 
expression. The red fluorescence is emitted by the thiolated polymer.  
From Figure 17, it is evident that polymer-plasmid treated cells show an increase of 
polymer uptake (red) with increasing N/P ratio, but that GFP was not expressed in these 
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cells, as opposed to lipofectamine treated cells. However, no conclusions can be made 
regarding polyplex internalization. To determine whether plasmid was delivered into the 
cells, gel electrophoresis was performed on DNA extracted from transfected cells and cell 
media. The red fluorescence observed by thiolated polyplexes indicates that polymer is 
still present in the samples. Whether the polymer is located within or on the surface of 
cells cannot be determined from this assay. 
 
 
Figure 17. MCF-7 cells transfected with 20% thiolated NP1-40 polyplexes (a-e). Control groups (a) 
untreated, (b) plasmid and (c) lipofectamine. Incubation: 4 h at 37
o
C. 40 X objective; scale bar, 15 





3.3.3    Plasmid Internalization 
Upon internalization, polymeric carriers must overcome a number of intracellular 
challenges, including endolysosomal escape and cargo release, before the delivered genes 
can be expressed.
1, 2, 28, 80
 Typically, more than 95% of the cells in a culture internalize 
over 100,000 copies of the vector, but less than 50% the cells express the cargo.
2
 
To determine whether thiolated polyplexes were internalized, DNA was extracted 
from polyplex treated cells versus cell media. DNA samples were run on an agarose gel 
in order to assess the relative concentration of plasmid internalized by cells, versus the 
concentration of polymer still present in the cell media. Figure 18 shows the DNA 
extracted from cells and media in polyplex treated samples and control groups. Untreated 
cells and cells treated with polyplexes show only chromosomal DNA, as indicated by the 
bright upper band. The media samples collected from NP 1-10 polymer treated cells, on 
the other hand, show evidence of plasmid DNA, indicating that plasmid DNA did not 
internalize during the transfection. The upper and lower bands in these wells correspond 
to supercoiled and relaxed plasmid, respectively. This effect is also seen in the plasmid 
control group. Plasmid is not visible in media collected from N/P 20 and 40 transfections. 
We believe that the high electrostatic binding at these concentrations prevented plasmid 
release from polymer carriers. As a result, plasmid DNA and polymer bound to cell 
membrane were removed as part of cell debris in the purification process. Positive control 
lipofectamine samples exhibit plasmid and media, suggesting that some of the plasmid in 




Figure 18. Gel electrophoresis of DNA purified from cells and cell media shows that only 


















3.3.4    Uptake Inhibition 
The results obtained from GFP expression and gel electrophoresis suggest that 
thiolated polyplexes are not internalized by cells. Fluorescent images from the GFP 
expression assay, however, show that the red fluorescing polymer is present in cell 
samples. Since transfected cells are thoroughly washed with PBS post-transfection, we 
believe that the thiolated polymeric carriers have attached to the cell surface via disulfide 
linkages. A pathway inhibition assay, in which cells were treated with one of three 
pathway inhibitors prior to polyplex transfection, was performed to demonstrate the 
polyplexes bind to the cell’s surface.   
Endocytosis is subdivided into four main categories; (i) clathrin-mediated 
endocytosis, (ii) caveolae, (iii) macropinocytosis and (iv) phagocytosis.
74
 The first three 
pathways can be inhibited with monodansylcadaverine (MDC), filipin, and amiloride, 
respectively. MDC is an agent that blocks formation clathrin-coated pits. Filipin affects 





exchange in macropinocytosis and non-classical CAM-mediated endocytosis.
74, 75
 
Phagocytosis is more specific of immune cells and hence  is less relevant to our system.
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MCF-7 cells were treated with MDC, filipin, or amiloride prior to transfection. Figure 
19 shows that polyplex treated cells exhibited similar average fluorescence intensities 
regardless of inhibition. In all cases, fluorescence was significantly increased as 
compared to untreated cells, which exhibited minimal background fluorescence. These 
data validate that the inhibitors don’t affect potential binding of polyplexes to the cell 






Figure 19. Average fluorescence intensities obtained from untreated cells, un-inhibited polyplex 
treated cells, and polyplex treated cells inhibited with Filipin, MDC, an Amiloride treated cells after 
4  h transfection with 20%, N/P 40 thiolated polyplexes. Incubation: 4 h at 37
o
C. Results show that 
polyplexes are not internalized by the clathrin-mediated, caveolae assisted, or macropinocytosis 








3.3.5    Polymer-Cell Membrane Binding 
Electrostatic interactions between thiolated cationic polymers and DNA condense 
cargo into nanosized particles amenable for in vivo delivery. It is generally accepted that 
particles less than 150 nm are optimal for internalization.
82
 Studies have shown that free 
PAA with MW 15000 has a hydrodynamic radius of over 4.8-6.5 nm in the pH range of 
6.0-9.5.
83
 Internalization of uncomplexed free polymer would therefore be hindered by 
the polymers large size. Hence, to further verify polyplex binding to cell surfaces, 
uncomplexed polymer and polymer-plasmid complexes were delivered to cells. 
Uncomplexed thiolated polymer that doesn’t bind to the cell’s surface would be removed 
during PBS wash. As a result, fluorescent images of these cells would show little (if any) 
fluorescence.  
Figure 20 shows that average fluorescence intensities in polyplex-treated, polymer-
treated, and untreated control cells. At low N/P ratios the same fluorescence intensities 
are observed in treated and untreated cells. This low fluorescence is attributed to 
background noise and suggests that polymer binding at these N/P ratios is minimal. As 
N/P ratio increases, the average fluorescence also increases. We believe that the greater 
number of thiols present in these samples facilitate the formation of disulfide linkages 
between the polymer and proteins present on the cell membrane. In addition, Figure 20 
shows that polymer-treated cells display similar fluorescence intensities as cells 
transfected with polyplexes. This data once again suggests that polyplexes are not 
internalized by cells. We believe that the polymer binds to the cell membrane via 
disulfide bonds, which prevent the un-internalized polyplexes from being removed in the 




Figure 20. Average fluorescence intensities obtained from cells treated with 20% thiolated 
polyplexes, 20% tholated polymers (no plasmid), and untreated controls indicate no significant 
difference in polymer concentration between polyplex and polymer treated cells, suggesting that 














3.3.6    Binding Kinetics 
To determine whether polymer-membrane binding is a time dependent reaction, 
MCF-7 cells were incubated with polyplexes for over 30 min, 1 h, 2 h, and 4 h at 37
o
C. In 
addition, another set of MCF-7 cells was treated with thiolated polyplexes and incubated 
at 4
o
C to determine whether temperature affects the kinetics of polymer-membrane 
disulfide linking. N/P 40, 20% thiolated polyplexes were used for all time and 
temperature dependent assays because of their high fluorescence intensities. 
Data demonstrate that cell surface binding is time and temperature dependent. Figure 
21 shows that the average fluorescence intensities observed in polyplex treated samples 
increases with incubation time. Transfections carried out for 30 min, 1 h, and 2 h show no 
discernible difference in average fluorescence from untreated control groups. However, 
after 4 h of incubation fluorescence intensities doubled and remained relatively constant 
between the 4 h and 24 h time points. This data suggests that initial the polymer-cell 
membrane interactions are minimal. As a result, the polymer is removed in the wash step 
and the observed fluorescence is primarily due to background noise. At the 4 h time 
period there is a significant increase in average fluorescence intensity values, which we 
attribute to increased polymer-cell interactions. Since there is no further increase in 
fluorescence over the next 24 h, we conclude that the majority of polymer-cell 
interactions occur between 2-4 h of incubation.  
The temperature-dependent assay demonstrated that polymer-membrane binding is 
hindered at 4
o
C. As shown in Figure 22, cells treated with polyplexes at 4
o
C exhibit the 
same noise fluorescence intensity as untreated cells.  Studies show that the thiol-disulfide 
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exchange is highly dependent on temperature, with elevated temperatures facilitating the 
reaction.
84
 It is expected, therefore, that at 4
o
C there would be minimal (if any) disulfide 
interactions between thiolated polymers and cell surfaces. 
 
 
Figure 21. Average fluorescence intensities obtained from polyplex treated cells suggest that 












C indicate that polyplexes do not attach to cell surface at 4
o

















3.3.7    Cell Count 
Cell count was performed on with 20% thiolated polyplexes and non-thiolated PAA 
to determine whether thiols affect cytotoxicity. Control cells were treated with 
lipofectamine to compare the toxicity of polymers relative to a commercial transfection 
reagent. Untreated cells were used a negative control for toxicity. Cells treated with 
Triton X, which permeabilizes cells by disrupting membranes, were used as a positive 
control. Gross toxicity was determined by performing a cell count of treated cells relative 
to the untreated control group. Figure 23 shows that at N/P ratios 1-20, there is no 
significant difference in cell count between polyplex treated cells, lipofectamine and 
untreated controls. At N/P 40, the viability of cells treated with thiolated polyplexes 
drops to ~60%. We believe that the excess amount of polymer binding onto the cell 
surface significantly impacts cell viability.  
 
Figure 23. Percent cell count of polymer treated cells relative to an untreated control, suggests 
minimal toxicity at NP 1-40. Viability of thiolated polyplex treated cells decreases by ~40% at N/P 40. 
Count 48 h post-transfection. 
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3.4    Conclusions 
Although thiol-pendant chains improved the complex size and stability of polyplexes, 
as demonstrated by DLS and zeta potential data, cell transfection assays showed that free 
thiols impede polyplex internalization due to polymer-cell surface attachments. The 
extent of attachment is determined by the concentration of thiols present, with higher 
concentrated polymers binding more readily to cell surfaces. Cytotoxicity is also affected 
by thiolated polymers. At lower polyplex concentrations, polymers do not exhibit 
significant toxicity. However, at higher thiolated polymer concentrations the viability of 
cells drops to nearly half. The effects of thiols as determined by this study should be 
taken under consideration when synthesizing thiol-containing cationic polymers for gene 
delivery. The high binding between free thiols and polymer cell surfaces impedes 
internalization but may have potential in other applications such as tissue engineering, 









4.1    Abstract 
Fluorescent polymers have attracted much attention in a variety of biomedical 
applications including biosensing, immunology, tissue engineering and gene delivery.
85
 
In cellular studies, fluorescent polymers are employed in an attempt to gain a deeper 




The concept of using fluorescence in intracellular trafficking and cell imaging is not 
limited to fluorescent polymers. Organic dyes, fluorescent proteins, and lanthanide 
chelates are often employed in the biological field.
85
 However, the success of these 
biomaterials is limited due to challenges including photostability and toxicity.
85, 87, 88
 In 
gene delivery, for example, fluorescent dyes are conjugated onto delivery complexes to 
assess internalization efficiency and aid in the optimization of drug carriers.
88, 89
 The 
large size of the probes often interferes with the carrier’s delivery efficiency. Studies 
have shown that attachment of a dye onto the polymer carrier can reduce expression by as 
much as 95%.
89
 Protein reporters, such as green fluorescent protein (GFP) and its 
derivatives, have also been used to monitor gene expression.
86, 90
 However, the 
fluorescent signals of GFP and similar protein reporters, diffuse quickly within the 
cytoplasm of the cell during imaging, making it difficult to discern a single reporter 
molecule.
90
 Aggregation of fluorescent proteins within the cell can lead to cell toxicity.
85
 
Finally, fluorescent markers, such as fluorescein, are susceptible to photobleaching, 
thereby compromising image contrast, quality, and prohibiting long-term monitoring of 
cells.
87, 88
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Fluorescent polymers offer the same advantages as fluorescent probes while avoiding 
the problem of delivery interference, the additional cost of probes, and potential 
photobleaching. As a result, fluorescent polymers are being investigated for a number of 
biological applications. Highly fluorescent nanoparticles, also known as “polymer dots”, 
for example, show higher photostability than molecular florescent probes and can be 
applied to cell imaging, ultrathin films or structured particles.
87, 91
 Fluorescent polymers 
that quench upon protein interaction can used to identify biomarker proteins in early 
disease detection.
92, 93
 Finally, fluorescent polymers offer the opportunity for more 




The application of fluorescent polymers in cellular assays would greatly improve the 
quality of cell imaging and significantly impact our understanding of cellular processes, 
allowing for the development of new and more reliable techniques. However studies 
show that the optical and electrochemical properties of fluorescent polymers are strongly 
affected by small perturbations in the environment, including changes in temperature, pH, 
and solvent.
96, 97
 Fluorescent conjugated polymers, for example, can be quenched very 
quickly in the presence of charged molecules.
97
 In this paper we explore optical changes 
in a thiol-containing fluorescent polymer with respect to inter- and intra- polymer chain 




4.2    Experimental 
4.2.1    Materials 
Poly(allylamine) solution (PAA) (MW 15000) was purchased from PolySciences Inc. 
2-iminothiolane (2-IT, Traut’s reagent) and 5,5'-dithiobis-(2-nitrobenzoic acid) (DNTB) ( 
Ellman’s reagent) were purchased from Thermo Scientific. Millipore-Amicon Centrifugal 
Filter Units (MW cutoff of 5000 Da) were purchased from Millipore. pEGFP-N1 (4700 
base pairs) plasmid was purchased from CLONTECH Laboratories and cloned it with 
Top 10 competent cells from Invitrogen. Extractions were carried out by HiSpeed 
Plasmid Maxi Kit purchased from Qiagen. Ethidium bromide, ethylenediaminetetraacetic 
acid powder (EDTA), dextran, Texas red dextran (MW 10,000), were purchased from 
Fisher Scientific. Dulbecco's Modified Eagle Medium and was purchased from 
Invitrogen. Phosphate buffered saline (PBS) pH 7.4, molecular grade was purchased from 
Sigma. Fetal bovine serum (FBS) was purchased from Cellgro. Label IT Tracker 











4.2.2    Methods 
4.2.2.1    Polymer Synthesis  
Thiolated polymers were synthesized by functionalizing 20% of the amines on a 
poly(allylamine) (PAA) backbone as previously described. Briefly, PAA was suspended 
in solution containing ethylenediaminetetraacetic acid powder (EDTA) and 2-
Iminothiolane (Traut’s reagent). The reaction was run at room temperature (RT) for 2 h 
to allow for conjugation of thiol chains onto the primary amines of PAA. Synthesized 
polymers were washed with PBS using Milipore Centrifugal Filter units at 8000 g. 
Filtered samples were suspended in PBS and stored at -80
o
C. Synthesis was verified by 
DNTB and 
1
H NMR.  
4.2.2.2    Polymer Fluorescence  
Fluorescence of thiolated polymers was verified by UV plate reader. Briefly, 0.005, 
0.025, 0.05, 0.10, and 0.20 mg/mL of thiolated and non-thiolated polymers, 2-IT, and 
EDTA were suspended in PBS, pH 7.4 in a 96 well plate. Polymer concentrations 
correspond to polyplex N/P ratios previously used. The fluorescence intensity of all 
samples was measured with a plate reader at ex/em ~595/620 nm. Fluorescently labeled 
polymer, Texas red dextran, was used as a positive control. The fluorescence intensity of 
PBS was also measured and subtracted from sample readings to remove background 
noise.  
Fluorescence was measured at various time points over a 24 h time period to assess 
fluorescence stability. After 24 h, 10 l 0.1 M HCl was added to all solutions to 
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determine whether acidic environments affect fluorescence. Fluorescence intensities were 
measured again and calculated as previously described.  
4.2.2.3    Fluorescent Microscope  
Thiolated polymer fluorescence was confirmed by fluorescent microscopy. Briefly, 
thiolated polymers were fixed at concentrations mentioned above on gelatin coated 
coverslips using 2% paraformaldehyde (PFA). Subsequently, coverslips were attached to 
glass slides using Mowiol. Samples were visualized using an Olympus IX81 fluorescence 
microscope (Olympus) and a 40X objective. Fluorescent images were obtained with an 
ORCA-ER camera (Hamamatsu Corporation) and SlideBook™ 4.2 software (Intelligent 
Imaging Innovations, Inc.). Fluorescence images were analyzed using Image-Pro 6.3 
software (Media Cybernetics, Inc). 
4.2.2.4    Protein Induced Fluorescent Quenching 
Polymer-protein quenching was demonstrated by incubating thiolated polymers in 
Dulbecco’s Modified Eagle Medium (DMEM) containing fetal bovine serum (FBS).  
Briefly, thiolated polymers were suspended at the concentrations mentioned above in 
phenol-free or phenol-supplemented media containing 10% FBS. Fluorescence was 
measured at the same polymer concentrations and with the same control group as above.  
4.2.2.5    Polymer-Plasmid Interactions 
Often in in-vitro delivery studies, DNA cargo is labeled with a molecular probe so 
that the DNA’s pathway within the cell can be visualized. Intracellular trafficking allows 
researchers to identify the rate-limiting step in the transfection process. To determine 
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whether polymer-plasmid interaction affect the probe’s fluorescence properties, thiolated 
polymer and fluorescein labeled plasmid DNA were complexed (polyplexes) at N/P 
ratios of 1, 5, 10, 20, and 40 in a 96-well plate at RT for 45 min. Plasmid labeling was 
carried out by Mirus Label IT kit according to manufacturer protocol. After incubation, 
fluorescent intensities of polyplexes were determined by plate reader at an ex/em 
~492/523 and compared to uncomplexed plasmid. The experiment was performed in PBS 
and serum-free DMEM. 
4.2.2.6    Statistical Analysis 
All experiments were performed in quadruplicate. Data is presented as the average 
and corresponding standard deviation of the mean (SEM) of four (n= 4) separate sample 










4.3    Results and Discussion 
4.3.1    Polymer Fluorescence  
Fluorescence is a phenomenon in which certain electrons in a molecule transition 
from ground state to excited state by absorbed light. As the electron return to ground 
state, some of the energy absorbed is emitted as fluorescence. Literature shows that 
molecules containing ‘’ electrons (also known as delocalized electrons) or ‘lone pair’ 
electrons (particularly those associated with N, O, P, and S atoms) are capable of 
fluorescence.
98
 In the present study, we developed a fluorescent polymer by conjugating 
thiol pendant chains onto the primary amines of PAA using 2-IT as previously 
described.
99
 The resulting fluorescent polymer contained ‘’ bonds as well as lone pair 
electrons associated with thiolates, and demonstrated increased photosensitivity at ex/em 
~595/620 nm. 
To verify fluorescence of thiol containing polymers, fluorescent intensities of 
thiolated and non-thiolated polymers, as well as EDTA and 2-IT were measured by plate 
reader. EDTA and 2-IT were utilized in the synthesis of thiolated polymers. Hence, the 
fluorescence intensities of these reagents were measured to ensure that the fluorescent 
properties observed in thiolated polymer samples resulted from the polymer itself, rather 
than residual reagents in solution. Fluorescently labeled polymer, Texas-red dextran, was 
used as a positive control. As shown in Figure 24, non-thiolated PAA, EDTA, and 2-IT 
did not display any fluorescence. Thiolated polymers displayed a concentration 
dependent increase in fluorescence. At low polymer concentrations, minimal (if any) 
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fluorescence was observed in thiolated polymers. However, at the highest .2 mg/ml 
concentration, fluorescence values reached ~1000 a.u. 
We attribute polymer fluorescence to interactions between thiolate lone pair electrons 
and ‘’ orbitals of C=N bonds. Previous studies have shown that thiols (SH) form highly 
nucleophilic thiolates (S-) in aqueous solution.
100
 Thiolates contain three lone pair 
electrons and are capable of charge transfer-transitions.
101
The active role of thiolates in 
fluorescence has been well documented.  Farrar et al.,
101
 for example, demonstrated that 
charge energy transfers between thiolate lone pair electrons and ‘’ orbitals of copper(II) 
give rise to the optical properties of copper proteins, known as cupredoxins. We believe 
that thiolates, formed from conjugated thiol groups, destabilized the ‘’ orbitals of C=N 
bonds, giving rise to the polymers fluorescence. In general, any influence that 
destabilizes ‘’ electrons increases fluorescence a molecule’s fluorescence, whereas ‘’ 
orbital stabilization diminishes fluorescence.
98
 Further, we reason that larger 
concentration of thiols and double bonds in higher concentrated polymer samples 
facilitated ‘’ electron destabilization, resulting in higher fluorescence intensities.  
Thiolated polymer fluorescence was further verified by fluorescence microscopy. As 
with UV readings, fluorescent microscopy showed that fluorescence intensity increased 
with polymer concentration. Figure 25 shows the sum fluorescence intensities of thiolated 
polymer samples as determined by Image-Pro 6.3 software. The polymer can be 




Figure 24. Fluorescence intensities of thiolated and non-thiolated polymers, EDTA, 2-IT, and Texas 












Figure 26. Image of thiolated polymer obtained by fluorescent microscope 
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4.3.2    Fluorescence Stability  
Over time, a decrease in fluorescence intensities was observed in thiolated polymer 
samples.  The phenomenon by which a molecule’s fluorescence intensity decreases is 
also known as “quenching”.
102
 Figure 27 shows that thiolated polymers fluoresced at t=0, 
but exhibited a rapid decline in intensity over a 24 h period. The fluorescence decrease 
was more rapid in higher concentrated polymer solutions. Within 1 h of incubation, the 
highest concentrated sample dropped from ~1000 a.u. to ~250 a.u., whereas minimal 
fluorescence decrease was observed at other concentrations. After 24 h the fluorescence 
intensity of all samples dropped below ~250 a.u. Non-thiolated PAA did not show any 
change in fluorescence over time (Figure 28). 
We attribute the fluorescent quenching in thiolated polymers to the formation of 
disulfide bonds. Previous studies have shown disulfide (S-S) form from thiols in an 
oxidation reaction. The reaction is spontaneous, but also time dependent, with the 
majority of thiol formation occuring within a 24 h period.
60
 Based on our knowledge of 
thiolate activity in fluorescence, we believe that the reduction of thiolates, due to 
disulfide formation, diminished ‘’ electron destabilization and hence decreased polymer 
fluorescence. Finally, we believe that high concentration polymer solutions exhibited a 
more rapid decline in fluorescence because disulfide formation occurs more rapidly as 
thiol concentration increases. Previous studies have demonstrated the correlations 
between disulfide formation and solution viscosity, suggesting that the close proximity of 







Figure 27. Fluorescence intensities of unmodfied PAA inidcate no fluorescence at ex/em ~595/620 
 
Figure 28. Fluorescence intensities of thiolated polymer indicate fluorescence instability at ex/em 
595/620. Quenching attributed to reduction of thiolates in solution due to disulfide bond formation. 
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4.3.3    Acid Effects 
pH-sensitive polymeric materials are often applied in drug delivery systems to trigger 
cargo release within the acidic environment of the lysosome.
103
 Our studies showed that 
the addition of HCl to already quenched thiolated polymers temporarily increased 
fluorescence values. As shown in Figure 29, quenched thiolated polymers demonstrate a 
brief rise in flurescence upon the addition of HCl (t=0). However, within the first 15 min 
of HCl treatment, fluorescence values decreased between 200-600 a.u.  After another 15 
min, fluorescence intensities dropped to zero. This effect was not obsereved in non-
thiolated polymers (Figure 30). 
When studying the effects of thiolates on the emission of nanocrystal quantum dots 
(NQD), Jeong et al., concluded that thiol-thiolate concentrations, which are influenced by 
absolute initial thiol concentrations, pH, and reaction times, significanlty impact the 
systems photoluminescence. Overall, the study suggested that thiolates, rather than thiols, 
were responsible for NQD optical proerties. However, thiolates played a dual role, both 
enhancing and decreasing photoluminescnece.
100
 We believe that the fluorescent effects 
exhibited upon titration resulted from shifts in the thiol-thiolate conentrations resulting 
from the addition of HCl.  Acidic environments favor the protonated thiol form over 
thiolate groups. However, the mechanism behind the drastic but brief increase in 




Figure 29. Fluorescent intensities of quenched thiolated polymers indicate rapid but brief increase in 
fluorescence at ex/em 595/620 after addition of HCl. 
 
Figure 30. Fluorescence intensities of non-thiolated PAA do not change upon addition of HCl. 
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4.3.4    Protein Interactions 
Conjugated fluorescent polymers have generated significant interest in sensor 
applications because of their efficient quenching in the presence of small molecule 
energy and electron acceptors.
104
  In studies requiring cellular imaging, such as in-vitro 
polymeric gene delivery, polymer quenching could significanlty impact data accuracy. To 
determine whether serum proteins could affect the fluorescent proerties of thiolated 
polymers, polymers were suspended in DMEM(-phenol) and DMEM(+phenol) 
containing 10% FBS. Figure 31, shows that the presence of serum proteins immediately 
quenches polymer fluorescence in both phenol supplemented and phenol free media. 
Although it is possible that quenching occurs as a result of disulfide binding between 
thiolaed polymers and serum proteins containing thiol groups, we believe that the process 
is primarily driven by polymer-protein electrostatic interactions. In the previous assays, it 
took 24 h for complete quenching to occur in phenol-supplemeneted and phenol-free 
medias. In the presence of FBS, however, quenching is instantaneous in both media 
types. The rapidity of this reaction leads us to believe that static quenching due to 
polymer-protein electrostatic interactions, not disulfide bonding, is the primary drive 
behind the quenching effect. Previous studies have shown that static quenching, which 
requires the formation of a polymer-quencher complex, can from coulomb driven 








Figure 31. Flurecence intensities of thiolated polymer in +/ –phenol FBS supplemented media 















4.3.5    Polymer-Probe Interactions 
In addition to polymer quenching, the quenching of fluorescent probes required for 
intracellular trafficking applications may also lead to incorrect data analysis. Previous 
studies have demonstrated probe quenching in the presence of two fluorescent reporters.  
Mishra et al.
106
 showed that the fluorescence signal of YOYO-1 labeled plasmid DNA 
was quenched upon complexation with a rhodamine labeled beta-cyclodextrin containing 
polymer. This quenching effect was not observed when labeled plasmid was complexed 
with non-rhodamine labeled DNA.
106
 To our knowledge, potential quenching of a 
molecular probe upon contact with a fluorescent polymer has not been investigated.  
In the case of gene delivery, fluorescent molecular probes are often conjugated onto 
the genetic cargo for intracellular trafficking. In this study, plasmids were labeled with 
fluorescein reporter molecules prior to complexation with polymer in DMEM or PBS. 
Fluorescence intensities of labeled plasmid complexes were compared to uncomplexed 
fluorescein-plasmid controls. Results demonstrate that complexation quenched 
fluorescein in DMEM but not PBS. In DMEM, fluorescein labeled plasmid displays 
fluorescent intensity values of ~225 a.u. (Figure 32). At N/P 1 complexes solutions 
display about half the fluorescence intensity of the uncomplexed plasmid control. At N/P 
5, the fluorescein signal is reduced to nearly 20%.  Finally, at N/P values 10, 20, 40 the 
fluorescein is nearly undetectable. Polyplexes formed in PBS, on the other hand, did not 




Figure 32. Fluorescein signal of labeled plasmid is quenched after complexation in DMEM. 
 
Figure 33. Fluorescein signal of labeled plasmids remains stable upon complexation in PBS. 
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4.4    Conclusions 
Fluorescent polymers have the potential to simplify intracellular trafficking assays by 
eliminating the need for fluorescent molecular probes. In gene delivery, for example, 
fluorescent polymers can be used to visualize the polyplex delivery pathway 
intracellularly and identify any potential rate-limiting steps that inhibit successful and 
efficient gene expression. However, the fluorescent properties of such polymers have not 
been adequately studied.  
Our research shows that environmental conditions can alter the polymers fluorescent 
qualities. Thiol-PAA exhibits its highest fluorescent intensities in PBS. We attribute the 
polymer’s fluorescence to arise from destabilization of ‘’ bonds by lone pair electrons of 
thiolates. Further, we believe that disulfide bond formation over time is responsible for 
fluorescence in quenching. Lowering the pH in this instance shifts the thiol-thiolate 
concentration and results in a rapid but brief increase in fluorescence.  We also observed 
that the fluorescent signal quenches in the presence of proteins. Finally, we determined 
that the polymers will quench the signal of a plasmid labeled with a molecular probe in 
DMEM. This affect is not observed in PBS.  
The data presented here signifies the importance of fully understanding a fluorescent 
polymers system prior to applying it in in vitro investigations. Preliminary experiments 
testing for changes in fluorescence under varying external conditions will allow for the 






A successful polymeric carrier for non-viral gene delivery must overcome a number 
of challenging extracellular and intracellular obstacles. Our preliminary data suggested 
that thiolated polymers are more suitable DNA carriers than non-thiolated polymers. For 
example, unlike unmodified PAA, all thiolated polymers were able to condense DNA. 
Further, at high N/P ratios, thiolated polymers were able to protect cargo DNA from 
degradative enzymes. In addition, all thiolated polymers exhibited higher buffering 
capacities than unmodified PAA, and therefore have a greater potential for 
endolysosomal escape. Further analysis indicated that the degree of disulfide crosslinking 
in thiolated polymers significantly impacted these properties. For example, highly 
crosslinked 5% thiolated polymers demonstrated superior cargo binding over 13% and 
20% thiolated carriers, but were unable to release gene cargo. At the same time, 20% 
thiolated polymers, which had the greatest buffering capacity and potential for 
endolysosomal escape, were also inefficient at DNA binding and release. Further, 20% 
thiolated polymers were the least effective in protecting gene cargo. The N/P 20 and 40, 
20% thiolated polyplexes were the exception to the 20% polyplex formulations, 
exhibiting high binding and release kinetics. In the end, the polyplexes with the greatest 
delivery potential overall, were the 13% thiolated polymers. Although 13% polyplexes 
showed partial degradation in the presence of DNase, they also achieved approximately 






Despite the positive results obtained from preliminary studies, all thiolated and non-
thiolated polymers failed to deliver plasmid DNA to MCF-7 cells. Cell transfection 
assays showed that free thiols impede polyplex internalization due to polymer-cell 
surface attachments. The extent of attachment was determined by the concentration of 
thiols present, with higher concentrated polymers binding more readily to cell surfaces. 
Thiolated polymers also caused significant toxicity at high N/P ratios. The effects of 
thiols as determined by this study should be taken under consideration when synthesizing 
thiol-containing cationic polymers for gene delivery. The high binding between free 
thiols and polymer cell surfaces impedes internalization but may have potential in other 
applications such as tissue engineering, medical implants, and biosensors where cell 
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